Pepdexpepdex
← All compounds

Letrozole

Femara · Aromatase inhibitor

Research reference only. Pepdex does not sell, supply or track this compound, and nothing here is guidance to use it — this page exists so the evidence and the risks are visible.

What it is

A potent breast-cancer aromatase inhibitor that also circulates in AAS contexts for estrogen suppression.

What human evidence shows

Oncology-grade evidence for estrogen suppression — near-complete at prescription doses. In men and in non-medical contexts there is no controlled evidence base, and excessive estrogen suppression is a real, documented state.

Risks

Excessively suppressed estrogen is its own syndrome — low libido, joint pain, mood deterioration, lipid damage, and bone-density loss with time; recovery varies. In men, chronic low estrogen is a documented path to osteoporosis.

Legal status

US: prescription-only. Products outside licensed dispensing are unapproved and of uncertain concentration.

Evidence base

S5,353 research papers
established literature

Large human evidence base: several phase 3 or 4 trial reports, plus multiple meta-analyses or systematic reviews.

phase 3/4
170
randomised
574
reviews
175
human trials
810

Counts are of published papers, not distinct trials, and measure how much research exists — not whether this works or is safe for you.

Research (12)

Turn Letrozole into a plan that's yours

The info above is free. Membership makes it personal, the Coach answers questions about your exact stack, the Stack tracks it for you, and the Verified Sources shows you how to vet what you buy.

  • AI Coach, ask anything about your stack. It does the dosing math, flags interactions, and tells you what to do next.
  • Personal Stack, save your protocol, track it across devices, log doses, get a heads-up before a vial runs out.
  • Verified Sources, the vetted reference for checking quality and sourcing, members only.
Become a member, from $4.99/week

Cancel anytime · or save with $59.99/yr · Coach + Stack included

Where next